Carotid plaque echolucency increases the risk of stroke in carotid stenting: The Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) study  by Biasi, G.M. et al.
Protected carotid-artery stenting versus endarterectomy in high-risk
patients
Yadav JS, Wholey MH, Kuntz RE, et al. New Engl J Med 2004;351:1493-
501.
Conclusion: Carotid stenting with the use of an emboli-protection
device is not inferior to carotid endarterectomy for treatment of severe
carotid artery stenosis in patients considered at high risk for carotid endar-
terectomy.
Summary: This is a long awaited publication of the Stenting and
Angioplasty with Protection in Patients at High Risk for Endarterectomy
(SAPPHIRE) trial. The authors conducted a randomized trial comparing
carotid artery stenting with an emboli-protection device versus carotid
endarterectomy in 334 patients with coexisting medial or anatomic condi-
tions that may increase the risk of carotid endarterectomy. Patients included
in the trial had at least 50% symptomatic carotid artery stenosis, or if the
lesion was asymptomatic, a stenosis of at least 80%. The primary end point
was somewhat unusual in that it consisted of cumulative incidents of
cardiovascular events in 1 year. These included a composite of death, stroke,
or myocardial infarction within 30 days after the intervention, or death or
ipsilateral stroke between 31 days and 1 year. Recurrent carotid stenosis was
not an end point.
The primary end point occurred in 20 patients assigned to the carotid
stenting with an embolic-protection device group (cumulative incidence,
12.2%) and in 32 patients who underwent carotid endarterectomy (cumu-
lative incidence, 20.1%; absolute difference, 7.9% ; 95% confidence inter-
val, 16.4% to 0.7%; P  .004 for non-inferiority, and P  .053 for
superiority). In this study, approximately 20% of the patients were80 years
old and 22%were entered for recurrent carotid stenosis. Less than 30% of the
patients had symptomatic stenosis. There were no differences in the cumu-
lative incidence of the primary end point at 1 year in the patients with
symptomatic stenosis (16.8% among those who received a stent vs 16.5%
among those who underwent endarterectomy, P  .95). For patients with
asymptomatic carotid stenosis, the cumulative incidence of the primary end
point at 1 year was lower among those who received a stent (9.9%) than
among those that underwent carotid endarterectomy (21.5%), P  .02.
Comment:This study, first published inUSAToday, has now appeared
in theNew England Journal of Medicine. The differences in the primary end
points between the endarterectomy and stented group appear to be primarily
driven by the higher number of myocardial infarctions, primarily non-Q
wavemyocardial infarctions, in the endarterectomy group. Nearly 75% of the
patients were treated for asymptomatic stenosis. The applicability of the
results of this trial for the overall care of patients with carotid artery disease
seems limited. Given the narrow therapeutic index of intervention for
asymptomatic carotid stenosis, particularly recurrent carotid stenosis, it is
likely the large majority of patients entered into the trial would not have
been, in many practices, suitable candidates for any carotid intervention,
regardless of whether it was endarterectomy or stent.
Late survival after elective repair of aortic aneurysms detected by
screening
Taylor JC, Shaw E, Whyman MR, et al. Eur J Vasc Endovasc Surg 2004:
270-3.
Conclusion: Men who undergo elective repair of an abdominal aortic
aneurysm (AAA) originally detected by screening have better later survival
than men with AAAs discovered incidentally and repaired electively.
Summary:Between 1990 and 1998, 424men underwent elective AAA
repair. Aneurysm repairs were performed for 181 AAAs detected in an
aneurysm screening program and in 243 where the aneurysm was diagnosed
incidentally. Follow-up survival data were collected until 2003. There was a
minimum of 5 years of follow-up.
Postoperative 30-day mortality after AAA repair was lower in men
whose aneurysms were detected by screening (4.4%) compared with those
detected incidentally (9.0%). Similarly, 5-year survival (78% vs 65%) and
10-year survival (63% vs 40%) were better after repair of a screen-detected
AAA than after repair of an AAA detected incidentally (P .0003 at all time
intervals). Patients whose aneurysms were detected incidentally were re-
paired at an older age than those whose aneurysms were detected by a
screening study (71.23 years vs 67.1 years).
Comment: The greater the patient’s potential life span, the greater the
possibility of a procedure to prolong survival. The paper does not necessarily
indicate that aneurysm screening programs increase overall survival. The
paper does indicate that participants in aneurysm screening programs have
their aneurysms repaired at an earlier age and therefore have greater potential
to derive survival benefit from the procedure. The results may also indicate a
greater tendency of younger patients to participate in screening programs
than older patients.
Carotid plaque echolucency increases the risk of stroke in carotid
stenting: The Imaging in Carotid Angioplasty and Risk of Stroke
(ICAROS) study
Biasi GM, Froio A, Diethrich EB, et al. Circulation 2004;110:756-62.
Conclusion: Increased echolucency of carotid artery plaques increases the
risk of stroke associated with carotid artery angioplasty and stenting (CAS).
Summary: This is a report of 418 cases of CAS derived from the the
Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) Registry and
collected from 11 international centers. The authors used high-resolution
B-mode duplex scanners in conjunction with a computer-assisted index of
echogenicity (gray scale median [GSM]) to quantify carotid plaque echolu-
cency. GSMs were classified as25 or25. Neurologic deficits during CAS
and in the postprocedural period were recorded.
Overall, the rate of neurologic complications was 3.6% (major stroke,
1.4%; minor stroke, 2.2%). Eleven strokes occurred in patients whose carotid
plaque GSMs were25 (n 155, 7.1%), and 4 strokes occurred in patients
with GSMs  25 (n  263, 1.5%, P  .005). Patients with 85% carotid
stenosis had a higher rate of stroke (P  .03). Cerebral protection devices
appeared effective in patients with GSMs 25 (P .01) but did not appear
effective in those with GSMs  25. Multivariable analysis indicated that
GSM (odds ratio [OR], 7.11; P .002) and severity of stenosis (OR, 5.76;
P  .010) were independent predictors of stroke.
Comment: The data suggest that patients with more echolucent
plaques and with higher degrees of internal carotid artery stenosis are at
higher risk of neurologic complications with carotid artery stenting. The
embolic potential of soft (echolucent) plaques is obvious to all who have
visualized such plaques at the time of carotid endarterectomy. The authors
also suggest the higher neurologic complication rate in patients with more
severe stenosis may reflect a higher number of embolic particles associated
with crossing a tight lesion with an endovascular device.
A combination of statins and beta-blockers is independently associated
with a reduction in the incidence of perioperative mortality and non-
fatal myocardial infarction in patients undergoing abdominal aortic
aneurysm surgery
Kertai MD, Boersma E, Westerhout CM, et al. Eur J Vasc Endovasc Surg
2004;28:343-52.
Conclusion: A combination of statin and -blocker therapy in patients
undergoing abdominal aortic aneurysm surgery is associated with reduced
perioperative mortality and nonfatal myocardial infarction.
Summary: The authors studied 570 patients who underwent abdom-
inal aortic aneurysm repair between 1991 and 2001. Themean age was 69
9 years and 486 were men. Data were analyzed for clinical risk factors
(history of myocardial infarction, age 70, diabetes mellitus, renal failure,
stroke, pulmonary disease, and heart failure) as well as use of statins and
-blockers and whether they had undergone a dobutamine stress echo test.
The main end point was a composite of perioperative mortality and myocar-
dial infarction within 30 days of surgery.
Myocardial infarction or death occurred in 51 (8.9%) patients. The
incidence of the composite end point was lower in statin users compared
with nonusers (3.7% vs 11.0%, odds ratio [OR], 0.31; 95% confidence
interval [CI], 0.13 to 1.74; P  .01). The benefit for statin use remained
after correcting for covariants. -Blocker use was also associated with
reduction in the composite end point (OR, 0.24; 95% CI, 0.11 to 0.54).
Patients with more severe risk factors appeared to particularly benefit from a
combination of statin and -blocker use.
Comment: It is now well appreciated that -blockers lower perioper-
ative mortality and adverse cardiovascular events in patients undergoing
peripheral vascular surgery. It is also appreciated that statins lower long-term
mortality in patients with peripheral vascular disease. Emerging data such as
these indicate that statin therapy may also have beneficial effects in the
perioperative period as well.
Transient ischemic attacks are more than “ministrokes”
Daffertshofer M, Mielke O, Pullwitt A, et al. Stroke 2004;35:2453-8.
Conclusion: Transient ischemic attacks (TIA) are not so “benign,”
with significant risks of early stroke, death and disability.
Summary: The clinical significance of TIA is controversial. An esti-
mated 4.9 million people in North America do not seek medical attention
despite TIA symptoms (Neurology 2003;60:1429-34). In this study, the
authors compared a large cohort of hospitalized TIA and stroke patients
derived from a stroke quality-assessment study. Prehospital and in-hospital
procedures, symptoms, complications, outcomes, and therapies were de-
rived from a representative sample from stroke-treating hospitals (n 82) in
southwestern Germany. Follow-up was attempted 6 months after discharge.
Points analyzed include death or dependency in activities of daily living as
determined by a modified Rankin scale (mRS) of 3 to 6, Barthel index of less
than 95, or institutionalization in a nursing home.
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